Latest filing published 25 Nov 2019 for Oasmia Pharmaceutical AB, €8,203.
Filing timeline
BuySaleInsider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Neil Eric Yman: trading record in brief
Neil Eric Yman discloses dealings in Oasmia Pharmaceutical AB to Finansinspektionen. Activity is concentrated on a single trading day, 25 November 2019, with 2 filings.
On the market, this insider has only ever bought: 2 purchases, €9,195 in total. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay.
The latest filing, published on 25 November 2019, reports an open-market purchase of €8,203 in Oasmia Pharmaceutical AB. These figures are compiled from regulatory filings published by Finansinspektionen. They describe what insiders did and are not a recommendation.
Companies and markets linked to Neil Eric Yman
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 67,000 shares@ SEK 1.3089.2% of flowTeckningsrättISIN SE0013460540FI:csv-a0e848d782d33ead9caeCanonical exit: 23 Feb 2020 (T+90)
- 7,980 shares@ SEK 1.3210.8% of flowTeckningsrättISIN SE0013460540FI:csv-c752518718b8a5895cd1Canonical exit: 23 Feb 2020 (T+90)
2 of 2 declarations